All Press Releases
PILA PHARMA announces plans for an IPO in Q2-2021
Malmö, Sweden, 17h November 2020 PILA PHARMA AB, a Swedish biotech company, is pleased to announce the decision to list the company. The Initial Public Offering (IPO), aiming for listing of the company’s shares on one of the unregulated stock exchanges in Sweden, is targeted for Q2-2021.To facilitate the IPO process, Göteborg Corporate Finance (GCF) has been selected as the…
PILA PHARMA announces positive phase 2a results in people with type 2 diabetes and strengthening of the organization
PILA PHARMA announces positive phase 2a results in people with type 2 diabetes and strengthening of the organization
2018, 11, 07 — PILA PHARMA Press Release
Malmö, Sweden, 7th November 2018 PILA PHARMA announces good safety of XEN-D0501 following single doses in patients with type 2 diabetes PILA PHARMA AB, a pharmaceutical company based in Malmö, Sweden, is pleased to announce that on November 1st, 2018, the dosing of patients in its first trial PP-CT01, studying the safety and tolerability of XEN-D0501 in patients with type…